These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 30719108)

  • 41. Poor prognosis of hexokinase 2 overexpression in solid tumors of digestive system: a meta-analysis.
    Wu J; Hu L; Wu F; Zou L; He T
    Oncotarget; 2017 May; 8(19):32332-32344. PubMed ID: 28415659
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increased MALAT1 expression predicts poor prognosis in esophageal cancer patients.
    Huang C; Yu Z; Yang H; Lin Y
    Biomed Pharmacother; 2016 Oct; 83():8-13. PubMed ID: 27470544
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Analysis of the regulation of metastasis-associated lung adenocarcinoma transcript 1 on the biological behavior of breast cancer.
    He X; Miao Q; Yi Y; Hu W; Wu M; Wu Y; Zhang Q
    Transl Cancer Res; 2021 Apr; 10(4):1609-1619. PubMed ID: 35116487
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic significance of pretreatment plasma fibrinogen level in patients with digestive system tumors: a meta-analysis.
    Ji R; Ren Q; Bai S; Wang Y; Zhou Y
    Int J Biol Markers; 2018 Aug; 33(3):254-265. PubMed ID: 29874984
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pyruvate kinase M2 overexpression and poor prognosis in solid tumors of digestive system: evidence from 16 cohort studies.
    Wu J; Hu L; Chen M; Cao W; Chen H; He T
    Onco Targets Ther; 2016; 9():4277-88. PubMed ID: 27478385
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic Value of Long Noncoding RNA CRNDE as a Novel Biomarker in Solid Cancers: An Updated Systematic Review and Meta-Analysis.
    Zhou Y; Wang R; Xu T; Xie P; Zhang Y; Zhang A; Wang X; Yang C; Yang H; Zhu S
    J Cancer; 2019; 10(11):2386-2396. PubMed ID: 31258743
    [No Abstract]   [Full Text] [Related]  

  • 47. Association of lncRNA-p53 regulatory network (lincRNA-p21, lincRNA-ROR and MALAT1) and p53 with the clinicopathological features of colorectal primary lesions and tumors.
    Chaleshi V; Irani S; Alebouyeh M; Mirfakhraie R; Aghdaei HA
    Oncol Lett; 2020 Jun; 19(6):3937-3949. PubMed ID: 32391102
    [TBL] [Abstract][Full Text] [Related]  

  • 48. LncRNAs act as prognostic and diagnostic biomarkers in renal cell carcinoma: a systematic review and meta-analysis.
    Chen J; Chen Y; Gu L; Li X; Gao Y; Lyu X; Chen L; Luo G; Wang L; Xie Y; Duan J; Peng C; Ma X
    Oncotarget; 2016 Nov; 7(45):74325-74336. PubMed ID: 27527868
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Associations between novel genetic variants in the promoter region of
    Li Y; Bao C; Gu S; Ye D; Jing F; Fan C; Jin M; Chen K
    Oncotarget; 2017 Nov; 8(54):92604-92614. PubMed ID: 29190941
    [TBL] [Abstract][Full Text] [Related]  

  • 50. lncRNA MALAT1 overexpression promotes proliferation, migration and invasion of gastric cancer by activating the PI3K/AKT pathway.
    Zhu K; Ren Q; Zhao Y
    Oncol Lett; 2019 Jun; 17(6):5335-5342. PubMed ID: 31186750
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Deregulated HOXB7 expression predicts poor prognosis of patients with malignancies of digestive system.
    Liu FT; Chen HM; Xiong Y; Zhu ZM
    Minerva Chir; 2019 Oct; 74(5):422-430. PubMed ID: 28749115
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MALAT1: A long non-coding RNA highly associated with human cancers.
    Zhao M; Wang S; Li Q; Ji Q; Guo P; Liu X
    Oncol Lett; 2018 Jul; 16(1):19-26. PubMed ID: 29928382
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic Role of Phospho-STAT3 in Patients with Cancers of the Digestive System: A Systematic Review and Meta-Analysis.
    Li MX; Bi XY; Huang Z; Zhao JJ; Han Y; Li ZY; Zhang YF; Li Y; Chen X; Hu XH; Zhao H; Cai JQ
    PLoS One; 2015; 10(5):e0127356. PubMed ID: 26024373
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sp1 cooperates with Sp3 to upregulate MALAT1 expression in human hepatocellular carcinoma.
    Huang Z; Huang L; Shen S; Li J; Lu H; Mo W; Dang Y; Luo D; Chen G; Feng Z
    Oncol Rep; 2015 Nov; 34(5):2403-12. PubMed ID: 26352013
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long noncoding RNA MALAT1 associates with the malignant status and poor prognosis in glioma.
    Ma KX; Wang HJ; Li XR; Li T; Su G; Yang P; Wu JW
    Tumour Biol; 2015 May; 36(5):3355-9. PubMed ID: 25613066
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The expression of long non coding RNA genes is associated with expression with polymorphisms of HULC rs7763881 and MALAT1 rs619586 in hepatocellular carcinoma and HBV Egyptian patients.
    Motawi TMK; El-Maraghy SA; Sabry D; Mehana NA
    J Cell Biochem; 2019 Sep; 120(9):14645-14656. PubMed ID: 31009106
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical Significance of UCA1 to Predict Metastasis and Poor Prognosis of Digestive System Malignancies: A Meta-Analysis.
    Sun XD; Huan C; Qiu W; Sun DW; Shi XJ; Wang CL; Jiang C; Wang GY; Lv GY
    Gastroenterol Res Pract; 2016; 2016():3729830. PubMed ID: 28074092
    [No Abstract]   [Full Text] [Related]  

  • 58. Expression and prognostic significance of lncRNA MALAT1 in pancreatic cancer tissues.
    Liu JH; Chen G; Dang YW; Li CJ; Luo DZ
    Asian Pac J Cancer Prev; 2014; 15(7):2971-7. PubMed ID: 24815433
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Deleted in Breast Cancer 1 as a Novel Prognostic Biomarker for Digestive System Cancers: A Meta-Analysis.
    Liu J; Meng C; Li C; Tang K; Tang H; Liao J
    J Cancer; 2019; 10(7):1633-1641. PubMed ID: 31205519
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MALAT1 affects ovarian cancer cell behavior and patient survival.
    Lin Q; Guan W; Ren W; Zhang L; Zhang J; Xu G
    Oncol Rep; 2018 Jun; 39(6):2644-2652. PubMed ID: 29693187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.